Investigational Site Number :6420001

Bucharest 022328

0 studies enrolling now · 3 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis With Nasal Polyps, Type 2 Diabetes Mellitus

Studies at this site

• A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps — Running, not enrolling
• Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 Inflammation — Completed
• Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period — Completed